Supplement consumers in Brazil now have a novel, clinically researched antioxidant option for protecting their cells from damage: Setria Glutathione, a premium ingredient by Kyowa Hakko.
The Brazilian Health Regulatory Agency (ANVISA) has announced that Setria is approved as a health ingredient for use in dietary supplements and functional foods. This is a major milestone for the branded ingredient.
“We are delighted that Brazilian consumers looking to fight free radical damage will now have access to Setria,” said Karen Todd, MBA, RD, Vice President of Global Brand Marketing, Kyowa Hakko USA. “This is a milestone we’ve been eager to reach, and we look forward to working with our customers in Brazil to bring innovative products to market containing this high-quality ingredient.”
We are delighted that Brazilian consumers looking to fight free radical damage will now have access to Setria
Glutathione is an important antioxidant that helps to protect cells from damage caused by free radicals and other toxins. Setria Glutathione is a high-quality ingredient that has been clinically tested to support the immune system and overall health and wellness. This ingredient is commonly used in tablets, capsules, and powder applications as dietary supplements.
ANVISA promotes the protection of the Brazilian population’s health by executing sanitary control of the production, marketing, and use of products and services subject to health regulation, including related environments, processes, ingredients, and technologies, as well as the control in ports, airports, and borders.
The approval reflects Kyowa Hakko’s commitment to producing safe and effective ingredients that support health and wellness. Setria Glutathione is produced using an innovative fermentation process that ensures high purity and bioavailability. It is backed by clinical research and is certified by third-party organisations to ensure quality and safety.
